Ali Behbahani is a Partner and Co-Head of Healthcare at NEA, focusing on biopharmaceutical and medical device investments. He joined NEA in 2007 and has been involved in founding companies like Arcellx and Nkarta.
At firms with a similar stage, sector and check size.
One email when Ali's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAli Behbahani is a Partner and Co-Head of Healthcare at NEA, focusing on biopharmaceutical and medical device investments. He joined NEA in 2007 and has been involved in founding companies like Arcellx and Nkarta.
Ali Behbahani invests through New Enterprise Associates (NEA), which writes checks of $1M to $30M+ at pre-seed, seed, series a, series b.
A warm intro from a founder New Enterprise Associates (NEA) backed works best.
Morgan Stanley; Lehman Brothers; National Institutes of Health; Duke University; Healthcare Investment Banking Analyst at Lehman Brothers; Venture Associate at Morgan Stanley Venture Partners; consultant in business development at The Medicines Company.
Last updated 2026-10-15. Is this you? Ask for a correction.